Lundbeck
HLUN-B.CO
$7.05
Share price
0.07%
Change (1 day)
-2.94%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Earnings for Lundbeck (HLUN-B.CO)
Earnings in 2024 (TTM): A$0.84 Billion
According to Lundbeck 's latest financial reports the company's current earnings are A$3.18 Billion. , an increase over its 2023 earnings that were of A$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Lundbeck from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | A$0.86 B | 25.46% |
| 2023 | A$0.69 B | 21.69% |
| 2022 | A$0.56 B | 31.79% |
| 2021 | A$0.43 B | -4.53% |
| 2020 | A$0.45 B | -45.08% |
| 2019 | A$0.82 B | -33.97% |
| 2018 | A$1.24 B | 12.76% |
| 2017 | A$1.10 B | 94.32% |
| 2016 | A$0.56 B | -136.98% |
| 2015 | -A$1.54 Billion | -1258.1% |
| 2014 | A$0.13 B | -72.43% |
| 2013 | A$0.48 B | 4.31% |
| 2012 | A$0.46 B | -55.26% |
| 2011 | A$1.02 B | 6.64% |
| 2010 | A$0.96 B | -6.68% |
| 2009 | A$1.03 B |